$45.96
-1.65 (-3.47%)
At Close: Jul 31, 2026
Vericel to Present at the Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 17, 2021
08:30am, Wednesday, 10'th Mar 2021
CAMBRIDGE, Mass., March 10, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick C
2 Overvalued Biotech Stocks Still Worth Buying
06:33am, Thursday, 04'th Mar 2021
Sometimes valuation metrics can be deceiving.
Vericel Corporation (VCEL) CEO Nick Colangelo on Q4 2020 Results - Earnings Call Transcript
01:31pm, Wednesday, 24'th Feb 2021
Vericel Corporation (VCEL) CEO Nick Colangelo on Q4 2020 Results - Earnings Call Transcript
Vericel to Present at the SVB Leerink 10th Annual Global Healthcare Conference on Thursday, February 25, 2021
08:30am, Monday, 22'nd Feb 2021
CAMBRIDGE, Mass., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Co
Vericel Corporation (VCEL) Dips More Than Broader Markets: What You Should Know
06:57pm, Wednesday, 17'th Feb 2021
In the latest trading session, Vericel Corporation (VCEL) closed at $51.15, marking a -0.04% move from the previous day.
Has Vericel (VCEL) Outpaced Other Medical Stocks This Year?
12:08pm, Wednesday, 17'th Feb 2021
Is (VCEL) Outperforming Other Medical Stocks This Year?
Vericel to Participate in the BTIG Virtual MedTech Digital Health, Life Science & Diagnostic Tools Conference on February 18, 2021
08:30am, Tuesday, 16'th Feb 2021
CAMBRIDGE, Mass., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Co
Vericel Announces Termination of Shareholder Rights Agreement
08:30am, Friday, 12'th Feb 2021
CAMBRIDGE, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that its Boa
Vericel Corporation (VCEL) Moves to Strong Buy: Rationale Behind the Upgrade
12:51pm, Thursday, 04'th Feb 2021
Vericel Corporation (VCEL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Bull of the Day: Vericel (VCEL)
07:35am, Monday, 01'st Feb 2021
Bull of the Day: Vericel (VCEL)
Vericel Announces Appointment of Joe Mara as Chief Financial Officer
08:30am, Monday, 25'th Jan 2021
CAMBRIDGE, Mass., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, announced the appointment of
Vericel Announces Preliminary Fourth-Quarter and Full-Year 2020 Financial Results and Provides Business Updates
07:15am, Monday, 11'th Jan 2021
Record Quarterly and Full-Year Total Revenues
Vericel to Present at the 23rd Annual Needham Growth Conference on Friday, January 15, 2021
08:30am, Friday, 08'th Jan 2021
CAMBRIDGE, Mass., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Co
Vericel Announces Expansion of MACI Coverage by UnitedHealthcare to Include Patella and Multiple Cartilage Defects in the Knee
08:30am, Thursday, 07'th Jan 2021
CAMBRIDGE, Mass., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that UnitedH
Vericel: Biotech Leader In Engineered Tissue Solutions With Rapid Growth & Profitability
06:48pm, Monday, 04'th Jan 2021
Vericel is a high growth, disruptive biotechnology company with annual sales increasing at a 30% rate prior to the COVID-19 pandemic. The Company's tissue repair and restoration products are proprieta
Sign In
Buy VCEL